Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Survival”

123 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 123 results

Early research (Phase 1)Study completedNCT02603003
What this trial is testing

The"Fuzheng" Therapy of TCM to Improve the Survival Quality of Early-stage NSCLC by Intervening the CTCs

Who this might be right for
Non-small Cell Lung Cancer(NSCLC)
Shanghai University of Traditional Chinese Medicine 218
Testing effectiveness (Phase 2)UnknownNCT01131429
What this trial is testing

A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations

Who this might be right for
Neoplasms, LungCarcinoma, Non-Small Cell LungDrug Therapy+1 more
Chinese PLA General Hospital 60
Post-approval studies (Phase 4)UnknownNCT05229809
What this trial is testing

Clinical Trial of Yiqi Wenyang Jiedu Prescription in the Prevention and Treatment of Postoperative Metastasis and Recurrence of Gastric Cancer

Who this might be right for
Gastric Carcinoma
Jie Li 212
Large-scale testing (Phase 3)Looking for participantsNCT06555003
What this trial is testing

DEBIRI Plus Chemotherapy vs. Chemotherapy Alone in Colorectal Cancer Liver Metastases

Who this might be right for
Liver NeoplasmColorectal Cancer Metastatic
Tehran University of Medical Sciences 116
Large-scale testing (Phase 3)Looking for participantsNCT05352178
What this trial is testing

Metastasis-directed Therapy for Oligorecurrent Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer RecurrentProstate Cancer Metastatic+4 more
Universitaire Ziekenhuizen KU Leuven 873
Testing effectiveness (Phase 2)Study completedNCT00239980
What this trial is testing

Fragmin in Ovarian Cancer: Utility on Survival (FOCUS)

Who this might be right for
Ovarian Cancer
Ontario Clinical Oncology Group (OCOG) 77
Post-approval studies (Phase 4)Study completedNCT00055120
What this trial is testing

When to Start Anti-HIV Drugs in Patients With Opportunistic Infections

Who this might be right for
HIV InfectionsAIDS-Related Opportunistic Infections
National Institute of Allergy and Infectious Diseases (NIAID) 283
Not applicableUnknownNCT03797248
What this trial is testing

Prospective Cohort Study of Traditional Chinese Medicine for Survival of Patients With Early Breast Cancer

Who this might be right for
Early-stage Breast Cancer
Chang Gung Memorial Hospital 310
Testing effectiveness (Phase 2)Active Not RecruitingNCT03976843
What this trial is testing

Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 175
Not applicableActive Not RecruitingNCT06142357
What this trial is testing

Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Psoriasis

Who this might be right for
Moderate-to-severe Plaque Psoriasis
Novartis Pharmaceuticals 199
Post-approval studies (Phase 4)Study completedNCT00473980
What this trial is testing

Preoperative Non-steroidal Anti-inflammatory Drugs(NSAID) to Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer
Göteborg University 28
Not applicableUnknownNCT04587388
What this trial is testing

Towards Personalized Medicine for Refractory/Relapsed Follicular Lymphoma Patients: the Cantera/Lupiae Registry

Who this might be right for
Follicular LymphomaRelapsed/Refractory Follicular Lymphoma
European Hematology Association - Lymphoma Group 500
Testing effectiveness (Phase 2)Looking for participantsNCT07269041
What this trial is testing

Immune Tolerance Induction After Liver Transplantation

Who this might be right for
Liver TransplantationImmune ToleranceImmune Tolerance/Drug Effects+6 more
University of California, Los Angeles 12
Not applicableActive Not RecruitingNCT07745205
What this trial is testing

Holistic Evaluation of Approaches to Long-term Health & Survivorship

Who this might be right for
Adult Cancer SurvivorsAdult Cancer Patients
Jules Bordet Institute 500
Not applicableStudy completedNCT03849573
What this trial is testing

A Web-Based Tool to Improve Breast Cancer Survivorship

Who this might be right for
Breast CancerHormone Dependent NeoplasmsAdherence to Hormone Therapy
Northwestern University 84
Testing effectiveness (Phase 2)Study completedNCT03801915
What this trial is testing

Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers

Who this might be right for
Colon CancerPancreatic CancerCholangiocarcinoma+2 more
National Cancer Institute (NCI) 10
Not applicableStudy completedNCT00043615
What this trial is testing

Collection of Blood, Bone Marrow, Tumor or Tissue Samples

Who this might be right for
NeoplasmsPrecancerous Conditions
National Cancer Institute (NCI) 74
Post-approval studies (Phase 4)Study completedNCT04464434
What this trial is testing

Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Systemic SclerosisSystemic Scleroses, DiffuseScleroderma+5 more
UMC Utrecht 60
Early research (Phase 1)UnknownNCT01624077
What this trial is testing

Safety Study of Using Regulatory T Cells Induce Liver Transplantation Tolerance

Who this might be right for
Chronic Rejection of Liver Transplant
Nanjing Medical University 1
Early research (Phase 1)Looking for participantsNCT07238075
What this trial is testing

ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers

Who this might be right for
Advanced MalignancyAdvanced Solid CancersMetastatic Solid Tumors
Adcytherix SAS 290
Next Page